Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biotechnology and Bioprocess Engineering is Scopus-indexed (Q2, CiteScore 4.9), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Korean Society for Biotechnology and Bioengineering.
Checked against the index lists dated .
ISSN 1226-8372Verify ISSN ↗1976-3816Verify ISSN ↗
Publisher: Korean Society for Biotechnology and Bioengineering
Cost to publish: About US$3,890 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biomedical Engineering | 155 / 342 | 54th | Q2 |
| Biotechnology | 150 / 325 | 54th | Q2 |
| Applied Microbiology and Biotechnology | 66 / 134 | 51st | Q2 |
| Bioengineering | 98 / 168 | 41st | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1996–present, best quartile Q2, CiteScore 4.9.
Biotechnology and Bioprocess Engineering is Q2 in Biomedical Engineering (rank 155 of 342), Q2 in Biotechnology (rank 150 of 325) and Q2 in Applied Microbiology and Biotechnology (rank 66 of 134), by CiteScore 2025. It is ranked in 4 subject areas in all.
Biotechnology and Bioprocess Engineering is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.9, which places it in quartile Q2 at the 54th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.532, quartile Q3, with an H-index of 74.
The publisher lists an article processing charge of about US$3,890 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Biotechnology and Bioprocess Engineering is published by Korean Society for Biotechnology and Bioengineering. Its print ISSN is 1226-8372 and its online ISSN is 1976-3816.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biotechnology and Bioprocess Engineering has an h-index of 78 and a 2-year mean of 3.01 citations per paper (OpenAlex). Its Scopus CiteScore is 4.9, quartile Q2. On 2-year citations it ranks #150 of 322 Scopus journals in Biomedical Engineering.
Biotechnology and Bioprocess Engineering published 81 papers in 2025; its busiest recent year was 2024 with 120. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from South Korea (65.6%), China (11.1%) and United States (4.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.